News

October 12, 2022

Agilent Technologies opened a Dissolution Center of Excellence in Craven Arms, United Kingdom, on Oct. 12, 2022.

October 10, 2022

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

October 10, 2022

Amphista Therapeutics and Domainex will work together to develop treatments focusing on targeted protein degradation.

October 10, 2022

OGT has launched the SureSeq Myeloid Plus panel and OGT Universal NGS Complete Workflow.

October 07, 2022

Thermo Fisher’s new centrifuge technology is designed to enable efficient, sustainable cell culture harvesting.

October 07, 2022

Freudenberg Medical’s Heflix TPE tubing is a high purity TPE intended for bioprocessing applications.

October 06, 2022

The UK’s MHRA has approved Colonis’ melatonin oral solution for sleep onset insomnia in children and adolescents with ADHD.

October 06, 2022

H.I.G. Capital’s portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals.

October 06, 2022

Klucel xtend HPC is the latest addition to the company’s Klucel product line and further expands their controlled-release portfolio.

October 04, 2022

FDA has granted Fast Track designation for CUE-101, a treatment of recurrent/metastatic head and neck squamous cell carcinoma.